Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | TAS0313 |
Trade Name | |
Synonyms | TAS-0313|TAS 0313 |
Drug Descriptions |
TAS0313 is a cancer vaccine composed of 12 cytotoxic T-cell epitope peptides derived from tumor-associated antigens, which potentially induces antitumor immune activity (PMID: 33615628, PMID: 38060587). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Pembrolizumab + TAS0313 | Pembrolizumab TAS0313 | 0 | 0 |
TAS0313 | TAS0313 | 0 | 0 |